IDH1 and glioblastoma: The diagnosis of NOS GBM should be reserved for scenarios in which IDH evaluation cannot be performed.9,10 The cIMPACT-NOW (the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy) was established to rapidly integrate advances in brain tumor molecular pathogenesis into clinical practice.